TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Aspire Biopharma Holdings ( (ASBP) ) is now available.
Aspire Biopharma Holdings, a company in the biopharmaceutical industry, has entered into a new Equity Line of Credit (ELOC) Agreement with Arena Business Solutions Global SPC II, Ltd. on November 11, 2025. This agreement allows Aspire to direct Arena to purchase up to $100 million in shares of its common stock, providing financial flexibility and potential capital for future operations. Concurrently, Aspire and Arena have mutually terminated their previous ELOC Agreement, initially established on February 13, 2025, marking a strategic shift in their financial arrangements.
More about Aspire Biopharma Holdings
Average Trading Volume: 27,817,121
Technical Sentiment Signal: Sell
Current Market Cap: $5.31M
See more data about ASBP stock on TipRanks’ Stock Analysis page.